StonvexLoading…
StonvexCore line items from PNW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.42B | $1.15B | $5.34B | $4.21B | $2.39B |
Operating Income | Not available | $131.17M | $1.07B | $946.62M | $364.77M |
Net Income | Not available | $35.11M | $631.64M | $614.05M | $196.53M |
EPS (Diluted) | $1.48 | $0.27 | $5.05 | $4.93 | $1.54 |
Total Assets | Not available | $30.69B | $30.03B | $29.89B | $29.24B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $6.41M | $6.60M | $30.89M | $18.84M |
Free Cash Flow OCF − CapEx | Not available | $-393.06M | $-819.52M | $-626.79M | $-668.74M |
Shares Outstanding | Not available | 123.78M | 121.97M | 121.86M | 121.81M |